Human PGE2 Chemiluminescent Immunoassay Kit
Human PGE2 Chemiluminescent Immunoassay Kit is designed to quantitatively measure PGE2 present in serum, plasma, urine, saliva and culture media samples. After an overnight incubation, the plate is washed and the supplied chemiluminescent substrate is added. The substrate reacts with the bound PGE2-peroxidase conjugate and the intensity of the generated light emission is detected in a microtiter plate reader.
Prostaglandins are synthesized from arachidonic acid by cyclooxygenase (COX)-1 or -2, which convert the acid into PGH2. This is further processed by cytosolic or microsomal prostaglandin synthases to become PGE2 or one of several other prostanoids. Prostacyclin is the major cyclooxygenase product in blood vessel walls and it is present in inflammatory fluids in similar concentrations to PGE2. PGE2 is a potent vasodilator and produces hyperalgesia. PGE2 is produced by a wide variety of tissues and in several pathological conditions, including inflammation, arthritis, fever, tissue injury, endometriosis, and a variety of cancers.